BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17215390)

  • 1. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.
    Wang Y; Mao XO; Xie L; Banwait S; Marti HH; Greenberg DA; Jin K
    J Neurosci; 2007 Jan; 27(2):304-7. PubMed ID: 17215390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.
    Van Den Bosch L; Storkebaum E; Vleminckx V; Moons L; Vanopdenbosch L; Scheveneels W; Carmeliet P; Robberecht W
    Neurobiol Dis; 2004 Oct; 17(1):21-8. PubMed ID: 15350962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.
    Lunn JS; Sakowski SA; Kim B; Rosenberg AA; Feldman EL
    Dev Neurobiol; 2009 Nov; 69(13):871-84. PubMed ID: 19672955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
    Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
    Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis.
    Lowry KS; Murray SS; McLean CA; Talman P; Mathers S; Lopes EC; Cheema SS
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):127-34. PubMed ID: 11771768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.
    Lu L; Zheng L; Viera L; Suswam E; Li Y; Li X; Estévez AG; King PH
    J Neurosci; 2007 Jul; 27(30):7929-38. PubMed ID: 17652584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.
    Vargas MR; Johnson DA; Sirkis DW; Messing A; Johnson JA
    J Neurosci; 2008 Dec; 28(50):13574-81. PubMed ID: 19074031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death.
    Li B; Xu W; Luo C; Gozal D; Liu R
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):155-64. PubMed ID: 12654515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
    Schütz B; Reimann J; Dumitrescu-Ozimek L; Kappes-Horn K; Landreth GE; Schürmann B; Zimmer A; Heneka MT
    J Neurosci; 2005 Aug; 25(34):7805-12. PubMed ID: 16120782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS.
    Barbeito AG; Martinez-Palma L; Vargas MR; Pehar M; Mañay N; Beckman JS; Barbeito L; Cassina P
    Neurobiol Dis; 2010 Mar; 37(3):574-80. PubMed ID: 19914377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
    Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
    Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.